
Loading, please wait...

Loading, please wait...

Left ventricular reverse remodeling (LVRR) remains a primary goal for modern heart failure therapies. This process involves the reversal of left ventricular dilation and the restoration of cardiac function. Recently, the EXPANDed studies investigated how Mitral Transcatheter Edge-to-Edge Repair (M-TEER) influences this phenomenon across different patient populations. The research specifically analyzed the incidence and clinical impact of early LVRR, defined as a 10% reduction in LV dimensions within 30 days of the procedure.
Among patients with secondary mitral regurgitation (SMR), the study found that 64.1% experienced early LVRR after the procedure. Notably, these patients demonstrated superior clinical trajectories compared to those without early remodeling. At the one-year mark, the LVRR group showed a significantly lower rate of death or heart failure hospitalizations at 24.7%, compared to 35.9% in the non-LVRR group. Furthermore, these benefits occurred despite both groups achieving similar levels of MR reduction and quality-of-life improvements. Consequently, early structural changes appear to be a distinct predictor of long-term stability in SMR cases.
In the primary mitral regurgitation (PMR) cohort, approximately 73% of patients achieved early LVRR. While overall symptomatic improvements were comparable across the PMR group, specific sub-populations derived more profound benefits. Specifically, PMR patients with dilated ventricles who experienced LVRR had a significantly lower mortality rate of 3.8% compared to 14.0% in those who did not remodel. Therefore, Mitral Transcatheter Edge-to-Edge Repair provides critical survival advantages for patients with significant ventricular enlargement.
The investigators identified several independent factors associated with a higher likelihood of early remodeling. Hypertension and smaller baseline left ventricular end-systolic volumes (LVESV) both positively correlated with LVRR. Additionally, the absence of prior cardiac surgeries increased the odds of successful reverse remodeling. These findings suggest that early intervention before the onset of irreversible ventricular damage may optimize procedural outcomes.
In these studies, researchers defined early LVRR as at least a 10% reduction in left ventricular dimension or volume from baseline to 30 days post-procedure, as measured by independent core laboratories.
Yes, the studies showed that 73% of PMR patients experienced early LVRR compared to 64.1% of SMR patients. However, the association between LVRR and reduced death or hospitalization was particularly prominent in SMR patients.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Keßler M et al. Left Ventricular Reverse Remodeling after Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPANDed Studies. ESC Heart Fail. 2026 Mar 16. doi: undefined. PMID: 41839533.
Stone GW et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation. N Engl J Med. 2018;379(24):2307-2318.
Mack MJ et al. 1-Year Outcomes of Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The EXPAND Study. JACC Cardiovasc Interv. 2021;14(11):1195-1205.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The EXPANDed studies reveal that early LVRR after M-TEER significantly improves clinical outcomes in SMR patients and survival in PMR patients with dilated ...
7 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday